Aspen agrees deal to manufacture Johnson & Johnson’s Covid-19 vaccine candidate
Aspen has entered into a preliminary agreement to manufacture Johnson & Johnson’s COVID-19 vaccine candidate, if it does become successful. The vaccine candidate is currently undergoing clinical trials. Stavros Nicolaou, Senior Executive for Strategic Trade at Aspen joins CNBC Africa for more.
Thu, 05 Nov 2020 10:08:38 GMT
SIGN UP FOR OUR NEWSLETTER
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.